Results 31 to 40 of about 204,330 (266)

Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates

open access: yesInternational Journal of Infectious Diseases, 2018
In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care unit (ICU) stays who had recurrent Candida auris (C. auris) in blood despite antifungal therapy. C.
Adnan Alatoom   +6 more
doaj   +1 more source

Candida auris, what do paediatricians need to know? [PDF]

open access: yes, 2018
AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core   +1 more source

Worsening Spread of Candida auris in the United States, 2019 to 2021

open access: yesAnnals of Internal Medicine, 2023
BACKGROUND Candida auris is an emerging fungal threat that has been spreading in the United States since it was first reported in 2016. OBJECTIVE To describe recent changes in the U.S. epidemiology of C auris occurring from 2019 to 2021.
M. Lyman   +6 more
semanticscholar   +1 more source

Emergence of multidrug-resistant and opportunistic fungal infections due to Candida auris in intensive care units [PDF]

open access: yesCurrent Medical Mycology
Background and Purpose: An increasing number of invasive infections due to multidrug-resistant Candida species have been reported worldwide. Among these Candida species, Candida auris has attracted more attention in recent years due to major outbreaks in
Peetam Singh, Anita Pandey
doaj   +1 more source

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

open access: yesAntibiotics, 2020
Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide. Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole resistance and mortality.
Mahmoud Ghannoum   +11 more
doaj   +1 more source

Surface disinfection challenges for Candida auris: an in-vitro study [PDF]

open access: yes, 2018
The emerging pathogenic multidrug-resistant yeast Candida auris is an important source of healthcare-associated infections and of growing global clinical concern.
Akinbobola, A.   +9 more
core   +4 more sources

Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance

open access: yesmSphere, 2019
Candida auris has emerged as an outbreak pathogen associated with high mortality. Biofilm formation and linked drug resistance are common among Candida species. Drug sequestration by the biofilm matrix accounts for much of the antifungal tolerance.
E. G. Dominguez   +6 more
doaj   +1 more source

Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings.
Elena De Carolis   +8 more
doaj   +1 more source

Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris [PDF]

open access: yes, 2019
The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated our consciousness. The global threat from this multidrug-resistant yeast has generated a call to arms from within the medical mycology community.
Kean, Ryan, Ramage, Gordon
core   +2 more sources

Candida auris is Coming

open access: yesIndian Journal of Critical Care Medicine, 2022
How to cite this article: Hegde A. Candida auris is Coming. Indian J Crit Care Med 2022;26(5):543-544.
openaire   +2 more sources

Home - About - Disclaimer - Privacy